selected publications
- Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era. Circulation. 2024 Academic Article GET IT
- Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy. BMC pulmonary medicine. 2024 Academic Article GET IT
-
Retrospective assessment and Biologic Asthma Response Score reveal roadmap for switching biologics in severe asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
2023
Academic Article
GET IT
Times cited: 1 - Relationship Between the Response to Antibody Therapy and Symptoms of Depression and Anxiety Disorders in Patients with Severe Asthma. Journal of asthma and allergy. 2023 Academic Article GET IT
- The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma. ERJ open research. 2023 Academic Article GET IT
-
Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness.
The journal of allergy and clinical immunology. In practice.
2022
Academic Article
GET IT
Times cited: 14 -
Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months.
Journal of asthma and allergy.
2021
Academic Article
GET IT
Times cited: 20 -
Dupilumab Improves Asthma Control and Lung Function in Patients with Insufficient Outcome During Previous Antibody Therapy.
The journal of allergy and clinical immunology. In practice.
2020
Academic Article
GET IT
Times cited: 45 -
Chronic progressive pulmonary paracoccidioidomycosis in a female immigrant from Venezuela.
2019
GET IT
Times cited: 5